DiscoverLife and ScienceWhere hope knocks: Personalized therapies in rare disease
Where hope knocks: Personalized therapies in rare disease

Where hope knocks: Personalized therapies in rare disease

Update: 2022-07-07
Share

Description

New drug design methodologies allow us to contemplate designer medicines for

very small groups of patients or even individuals. The future holds

promise for the rare disease community because modern biotech can build

bespoke (customized) therapies. Are we at the dawn of personalized

treatments being widely available for individual patients? This poses a

broader question: Just as every person is unique, could all medicines

become so too?




This podcast is the audio recording of a webinar launched by AAAS / Science Magazine and Fondation Ipsen.




With:


Genine Winslow, M.Sc. (Chameleon Biosciences, San Anselmo, CA)
Tiina Urv, Ph.D. (National Institutes of Health, Bethesda, MD)
Viviana Giannuzzi, Pharm.D., Ph.D. (Fondazione Gianni Benzi Onlus, Bari, Italy)
Sean Sanders, Ph.D. (Science/AAAS, Washington, DC)


Hosted by Ausha. See ausha.co/privacy-policy for more information.

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Where hope knocks: Personalized therapies in rare disease

Where hope knocks: Personalized therapies in rare disease

Life and Science